EUVIMEDEUVIMED entdecken
Crossref

High-power short-duration radiofrequency ablation for atrial fibrillation: There is still a country for “old men”

Andrea Giuseppe Porto, Paolo Zappulla, Giuseppe Sgarito, Sergio Conti

World Journal of Cardiology · 26.07.2026 · 18 (7)

DOI: 10.4330/wjc.120973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Cardiology, online erschienen am 26.07.2026. Verfasst von Andrea Giuseppe Porto und 3 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-power short-duration (HPSD) and very-HPSD (vHPSD) radiofrequency (RF) ablation have emerged as important advances in catheter ablation for atrial fibrillation (AF). By delivering higher power over shorter durations, these approaches aim to improve lesion quality, procedural efficiency, and clinical outcomes while maintaining procedural safety. The recent introduction of pulsed-field ablation (PFA) has challenged the role of thermal energy sources and raised questions regarding the future position of HPSD RF ablation in AF treatment. This narrative review summarizes the current evidence regarding the biophysical principles, procedural characteristics, efficacy, and safety of HPSD and vHPSD RF ablation. Data from mechanistic studies, randomized controlled trials, observational studies, meta-analyses, and contemporary consensus documents were reviewed, with particular focus on pulmonary vein isolation, posterior wall isolation, linear ablation, and comparisons with emerging PFA technologies. HPSD and vHPSD ablation generate lesions predominantly through resistive heating, producing broader and more homogeneous lesions while reducing RF application time. Randomized trials and meta-analyses consistently demonstrate shorter procedure duration, reduced RF delivery time, improved first-pass pulmonary vein isolation, and non-inferior or superior arrhythmia-free survival compared with conventional low-power long-duration RF ablation. Safety outcomes are generally comparable, although concerns regarding steam pops and cerebral embolic events remain dependent on catheter technology and procedural protocols. While PFA offers a non-thermal, tissue-selective alternative with promising safety and efficiency profiles, emerging evidence suggests that clinical efficacy remains largely comparable between PFA and HPSD/vHPSD strategies. HPSD and vHPSD RF ablation represent mature, effective, and efficient approaches for AF ablation, supported by extensive mechanistic and clinical evidence. Despite the rapid adoption of PFA, current data do not support the replacement of HPSD RF ablation. Rather, HPSD is likely to remain an important component of contemporary AF ablation, complementing emerging non-thermal technologies and providing a versatile strategy across a broad range of clinical scenarios.

Zitieren

APA

Porto, A. G., Zappulla, P., Sgarito, G., & Conti, S. (2026). High-power short-duration radiofrequency ablation for atrial fibrillation: There is still a country for “old men”. World Journal of Cardiology, 18(7). https://doi.org/10.4330/wjc.120973

Vancouver

Porto AG, Zappulla P, Sgarito G, Conti S. High-power short-duration radiofrequency ablation for atrial fibrillation: There is still a country for “old men”. World Journal of Cardiology. 2026;18(7). doi:10.4330/wjc.120973

BibTeX
@article{Porto2026,
  author = {Porto, Andrea Giuseppe and Zappulla, Paolo and Sgarito, Giuseppe and Conti, Sergio},
  title = {High-power short-duration radiofrequency ablation for atrial fibrillation: There is still a country for “old men”},
  journal = {World Journal of Cardiology},
  year = {2026},
  volume = {18},
  number = {7},
  doi = {10.4330/wjc.120973}
}
Kostenlos starten →